0001883850-22-000063.txt : 20220908 0001883850-22-000063.hdr.sgml : 20220908 20220908160658 ACCESSION NUMBER: 0001883850-22-000063 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220906 FILED AS OF DATE: 20220908 DATE AS OF CHANGE: 20220908 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: COLES N ANTHONY CENTRAL INDEX KEY: 0001197018 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 221233903 MAIL ADDRESS: STREET 1: MORRIS CORP. CENTER I; BLDG. B; 4TH FLR. STREET 2: 300 INTERPACE PARKWAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2022-09-06 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001197018 COLES N ANTHONY 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 0 0 0 Common Stock 2022-09-06 4 M 0 2216 374.12 A 3309 D Common Stock 2022-09-06 4 S 0 300 576.73 D 3009 D Common Stock 2022-09-06 4 M 0 3784 371.4 A 6793 D Common Stock 2022-09-06 4 S 0 500 577.07 D 6293 D Common Stock 2022-09-06 4 S 0 273 578.25 D 6020 D Common Stock 2022-09-06 4 S 0 550 579.85 D 5470 D Common Stock 2022-09-06 4 S 0 688 580.44 D 4782 D Common Stock 2022-09-06 4 S 0 822 581.44 D 3960 D Common Stock 2022-09-06 4 S 0 1220 582.56 D 2740 D Common Stock 2022-09-06 4 S 0 1045 583.16 D 1695 D Common Stock 2022-09-06 4 S 0 602 584.57 D 1093 D Non-Qualified Stock Option (right to buy) 371.4 2022-09-06 4 M 0 3784 0.0 D 2029-01-02 Common Stock 3784 0 D Non-Qualified Stock Option (right to buy) 374.12 2022-09-06 4 M 0 2216 0.0 D 2030-01-02 Common Stock 2216 2145 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 300 shares of Company stock on September 6, 2022 at prices ranging from $576.34 to $576.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 6, 2022 at each separate price. Represents volume-weighted average price of sales of 500 shares of Company stock on September 6, 2022 at prices ranging from $577.00 to $577.10. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 6, 2022 at each separate price. Represents volume-weighted average price of sales of 273 shares of Company stock on September 6, 2022 at prices ranging from $578.00 to $578.52. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 6, 2022 at each separate price. Represents volume-weighted average price of sales of 550 shares of Company stock on September 6, 2022 at prices ranging from $579.00 to $579.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 6, 2022 at each separate price. epresents volume-weighted average price of sales of 688 shares of Company stock on September 6, 2022 at prices ranging from $580.12 to $580.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 6, 2022 at each separate price. Represents volume-weighted average price of sales of 822 shares of Company stock on September 6, 2022 at prices ranging from $581.08 to $581.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 6, 2022 at each separate price. Represents volume-weighted average price of sales of 1,220 shares of Company stock on September 6, 2022 at prices ranging from $582.31 to $582.80. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 6, 2022 at each separate price. Represents volume-weighted average price of sales of 1,045 shares of Company stock on September 6, 2022 at prices ranging from $583.00 to $583.52. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 6, 2022 at each separate price. On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that had passed from the date of grant became exercisable, and the remainder became exercisable on the first anniversary of the date of grant. By: Richard Gluckselig as attorney-in-fact For: N. Anthony Coles 2022-09-07